'did not reach theraputic levels severe pain', page-9

With all the talk on this forum recently about the importance of reading releases carefully, it appears that some of us have not taken that advice to heart.

Great point. Read between the lines of these:

Manufacturing and development is scheduled for early 2011 and phase 2/3 trials will start after patch completion.

and

We believe that initiating the commercial development of the TPM/oxycodone and using this product for the remaining phase 2/3 program provides the fastest route to registration and market.

and

Phosphagenics is now in advanced discussions with a leading patch manufacturer for the commercial scale-up of the finished patch product.

Commercial scale production with a leading patch manufacturer means quality and quantity. Path manufacture and development early 2011 to be followed immediately by phase 2/3 trials. If trial are successful, we are straight into commercialisation. Could be on the market well within 6-9 months.

This aint going to be 11c in 6 to 9 months time.